Publicaciones en colaboración con investigadores/as de Hospital Miguel Servet (15)

2021

  1. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

    Blood, Vol. 137, Núm. 14, pp. 1879-1894

  2. Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia

    Leukemia, Vol. 35, Núm. 8, pp. 2358-2370

2018

  1. Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy

    Modern Pathology, Vol. 31, Núm. 8, pp. 1318-1331

2016

  1. Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy

    Oncotarget, Vol. 7, Núm. 9, pp. 10174-10181

2013

  1. Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis

    Leukemia, Vol. 27, Núm. 11, pp. 2149-2156

2012

  1. Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: Are they present at diagnosis or are they induced by lenalidomide?

    Haematologica, Vol. 97, Núm. 10, pp. 1608-1611

2010

  1. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: A pilot study on A series of 56 patients

    Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. 3, pp. 154-168

2008

  1. Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: Analysis of a series of 432 patients

    Blood, Vol. 111, Núm. 10, pp. 5130-5141

  2. Association between the proliferative rate of neoplastic B-cells. Their maturation stage and underlying, their maturation stage and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders

    CELLULAR ONCOLOGY

  3. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia

    Cytometry Part B - Clinical Cytometry, Vol. 74, Núm. 3, pp. 139-149

  4. The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors

    Leukemia, Vol. 22, Núm. 6, pp. 1175-1183

2006

  1. Heterogeneity of neoplastic cells in B-cell chronic lymphoproliferative disorders: Biclonality versus intraclonal evolution of a single tumor cell clone

    Haematologica, Vol. 91, Núm. 3, pp. 331-339

2005

  1. Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation

    Leukemia, Vol. 19, Núm. 8, pp. 1376-1383

  2. Genetic heterogeneity of BCR/ABL+ adult B-cell precursor acute lymphoblastic leukemia: Impact on the clinical, biological and immunophenotypical disease characteristics

    Leukemia, Vol. 19, Núm. 5, pp. 713-720

2003

  1. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: Incidence and underlying genetic abnormalities

    Leukemia, Vol. 17, Núm. 6, pp. 1124-1129